Ngā hua rapu - Frede Donskov

Tumor-associated neutrophils as a new prognostic factor in cancer: a systematic review and meta-analysis. mā Meixiao Shen, Pingping Hu, Frede Donskov, Guanghui Wang, Qi Liu, Jiajun Du

Whiwhi kuputuhi katoa

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol mā Jakob N. Henriksen, Charlotte U. Andersen, Frede Donskov, Elke Hoffmann-Lücke, Eva Greibe, Niels Fristrup

Whiwhi kuputuhi katoa

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial mā Laura Iisager, Johanne Ahrenfeldt, Frede Donskov, Börje Ljungberg, Axel Bex, Lars Lund, Iben Lyskjær, Niels Fristrup

Whiwhi kuputuhi katoa

Therapies in Refractory Metastatic Renal Cell Carcinoma mā Stephanie Berg, Martin Angel, Kathryn E. Beckermann, Frede Donskov, Chung-Han Lee, Pavlos Msaouel, Rana R. McKay, Tian Zhang

Whiwhi kuputuhi katoa

Involving patient partners as appraisers of shared decision making: an explanatory sequential mixed-methods study mā Bettina Mølri Knudsen, Mette Byg Josefsen, Mona Muusmann Petersen, Poul Risom, Henriette Witte Nielsen, Frede Donskov, Stine Rauff Søndergaard, Karina Dahl Steffensen, Dawn Stacey, Lea Lund

Whiwhi kuputuhi katoa

Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma mā Chung-Wei Lee, Thomas Powles, Sabina Signoretti, Sumanta K Pal, Toni K Choueiri, Brian I Rini, Saby George, Robert J Motzer, Frede Donskov, Scott S Tykodi, Nizar M Tannir, Saurabh Gupta, Ruiyun Jiang

Whiwhi kuputuhi katoa

Clinical Outcomes by Nephrectomy Status In METEOR, A Randomized Phase 3 Trial of Cabozantinib Versus Everolimus in Patients with Advanced Renal Cell Carcinoma mā Nizar M. Tannir, Thomas Powles, Bernard Escudier, Frede Donskov, Viktor Grünwald, Cora N. Sternberg, Manuela Schmidinger, Patrick Schöffski, Cezary Szczylik, Katriina Peltolta, Dmitry Nosov, Bohuslav Melichar, Douglas Clary, Christian Scheffold, Robert J. Motzer, Toni K. Choueiri

Whiwhi kuputuhi katoa

Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC) mā Igor Stukalin, J. Connor Wells, Anna Fraccon, Felice Pasini, Camillo Porta, Aly-Khan A. Lalani, Sandy Srinivas, I. Alex Bowman, James Brugarolas, Jae-Lyun Lee, Frede Donskov, Benoit Beuselinck, Aristotelis Bamias, Brian I. Rini, Hao-Wen Sim, Neeraj Agarwal, Sun-Young Rha, Ravindran Kanesvaran, Toni K. Choueiri, Daniel Y.C. Heng

Whiwhi kuputuhi katoa

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic r... mā Martin Zarba, Dylan O’Sullivan, David Maj, Winson Y. Cheung, Lisa Ludwig, Connor Wells, Evan Ferrier, Razane El Hajj Chehade, Frede Donskov, Marc Eid, Sumanta Kumar Pal, Benoit Beuselinck, Rana R. McKay, Lori Wood, Jae Lyun Lee, Cristina Suárez, Kosuke Takemura, Ignacio Duran, Toni K. Choueiri, Daniel YC Heng, Daniel YC Heng

Whiwhi kuputuhi katoa

Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Rena... mā Chun Loo Gan, Shaan Dudani, J. Connor Wells, Frede Donskov, Sumanta K. Pal, Nazli Dizman, Nityam Rathi, Benoit Beuselinck, Flora Yan, Aly‐Khan A. Lalani, Aaron Hansen, Bernadett Szabados, Guillermo deVelasco, Ben Tran, Jae Lyun Lee, Ulka N. Vaishampayan, Georg A. Bjarnason, Mathushan Subasri, Toni K. Choueiri, Daniel Y. C. Heng

Whiwhi kuputuhi katoa

Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC) mā Steven M. Yip, Jose M. Ruiz Morales, Frede Donskov, Anna Fraccon, Umberto Basso, Brian I. Rini, Jae Lyun Lee, Georg A. Bjarnason, Hao-Wen Sim, Benoit Beuselinck, Ravindran Kanesvaran, James Brugarolas, Kostas Koutsoukos, Simon Yuen Fai Fu, Takeshi Yuasa, Ian Davis, Ajjai Alva, Christian Kollmannsberger, Toni K. Choueiri, Daniel Y.C. Heng

Whiwhi kuputuhi katoa

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a random... mā Howard Gurney, Thomas Powles, Asim Amin, Bohuslav Melichar, Camillo Porta, David F McDermott, Toni K Choueiri, Marc-Oliver Grimm, Bernard Escudier, Elizabeth R Plimack, Brian I Rini, Hans J Hammers, Saby George, Robert J Motzer, Alain Ravaud, Osvaldo Arén Frontera, Frede Donskov, Philippe Barthélémy, Viktor Grünwald, Victoria Neiman, Pamela Salman, Christian K Kollmannsberger, Scott S Tykodi, Raya Leibowitz-Amit, Poul F Geertsen, Yoshihiko Tomita, M Brent McHenry, Shruti Shally Saggi, Nizar M Tannir

Whiwhi kuputuhi katoa